Fig. 5From: Purification and biofabrication of 5-aminolevulinic acid for photodynamic therapy against pathogens and cancer cellsThe plate assay of aPDT using 5-ALA from (a, c, e) purified (NCKU) and (b, d, f) commercial (Sigma A3785) against pathogen Aeromonas hydrophila (a, b) Bacillus cereus (c, d), Staphylococcus aureus (e, f). The left and right sides of plate represented control (without 5-ALA) and experiment group (with 1% or 0.25% 5-ALA)Back to article page